Frontlight ResearchEarly access
Trial site
Retinal Consultants Medical Group, Inc.
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration8 trials
- Diabetic eye disease3 trials
- Melanoma2 trials
- Phase
- Phase 310 trials
- Phase 24 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Kodiak Sciences Inc4 trials
- 4D Molecular Therapeutics3 trials
- Aura Biosciences2 trials
- Novartis Pharmaceuticals2 trials
- Astellas Pharma Global Development, Inc.1 trial
- and 3 more
Running trials
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Enrolling by invitation
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic eye disease1 recruiting
- Macular degeneration1 recruiting
- Melanoma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
Site data: ClinicalTrials.govUpdated 13 Nov 2026